These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5710606)

  • 21. Drug-responsive symptoms during early neuroleptic treatment.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.
    Anand R; Geffen Y; Vasile D; Dan I
    Clin Neuropharmacol; 2010; 33(6):297-302. PubMed ID: 20921890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 24. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined antidepressant-tranquilizer therapy of mixed psychiatric syndromes.
    Feldman PE
    Psychosomatics; 1965; 6(5):312-5. PubMed ID: 5319240
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroleptic therapy following neuroleptic malignant syndrome.
    Pelonero AL; Levenson JL; Silverman JJ
    Psychosomatics; 1985 Dec; 26(12):946-7. PubMed ID: 4089133
    [No Abstract]   [Full Text] [Related]  

  • 28. The differential prediction of response to two anti-psychotic drugs.
    Goldstein BJ; Brauzer B; Clyde DJ; Caldwell JM
    Psychosomatics; 1969; 10(3):193-7. PubMed ID: 4897844
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ
    Biol Psychiatry; 1989 Mar; 25(6):734-8. PubMed ID: 2923935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic interaction between perphenazine and disulfiram.
    Hansen LB; Larsen NE
    Lancet; 1982 Dec; 2(8313):1472. PubMed ID: 6129552
    [No Abstract]   [Full Text] [Related]  

  • 31. Perphenazine serum levels in patients on standard doses.
    Haffner F
    Psychopharmacol Ser; 1989; 7():280-3. PubMed ID: 2687863
    [No Abstract]   [Full Text] [Related]  

  • 32. The comparative effectiveness of eight phenothiazines.
    Hanlon TE; Michaux MH; Ota KY; Shaffer JW; Kurland AA
    Psychopharmacologia; 1965 Feb; 7(2):89-106. PubMed ID: 5318926
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.
    Hansen LB; Larsen NE
    Psychopharmacology (Berl); 1977 Jul; 53(2):127-30. PubMed ID: 408838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The computer analyzes two psychotherapeutic agents in anxiety-depressed states.
    Falk MA
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):488-99. PubMed ID: 4198312
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
    Baumann P; Eap CB; Zullino DF
    J Nerv Ment Dis; 2001 Nov; 189(11):798-9. PubMed ID: 11758666
    [No Abstract]   [Full Text] [Related]  

  • 36. Alprazolam for psychotic depression.
    Coryell W; Moranville JT
    Biol Psychiatry; 1989 Feb; 25(3):367-9. PubMed ID: 2914162
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation.
    Lindholm H; Ljungberg L
    Acta Psychiatr Scand Suppl; 1973; 246():52-6. PubMed ID: 4520279
    [No Abstract]   [Full Text] [Related]  

  • 39. [Personality and the extrapyramidal side effects of perphenazine].
    Mäkelä S
    Nord Psykiatr Tidsskr; 1967; 21(2):136-44. PubMed ID: 5597915
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical treatment of post partum delirium with perfenazine and lithium carbonate.
    Silbermann RM; Beenen F; de Jong H
    Psychiatr Clin (Basel); 1975; 8(6):314-26. PubMed ID: 1233538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.